Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· June 29, 2026

DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer

View original at finance.yahoo.com

DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer RAYNHAM, Mass., June 29, 2026--(BUSINESS WIRE)--DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced the appointment of Christina Zamarro as Chief Financial Officer, DePuy Synthes, effective July 13, 2026…

Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

DePuy Synthes provides one of the most comprehensive orthopaedics portfolios in the world.
60% confidence
Johnson & Johnson is uniquely positioned to innovate across the full spectrum of healthcare solutions through expertise in Innovative Medicine and MedTech.
60% confidence
Christina Zamarro brings more than two decades of financial leadership and deep experience managing global and complex transformation programs.
60% confidence